Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, LP | Institution | 12.466.489 | 15,63% | US$ 131,33M | 2026-03-31 |
| Medicxi Ventures (UK) LLP | Institution | 7.464.572 | 9,36% | US$ 78,64M | 2026-03-31 |
| Frazier Life Sciences IX, L.P. | Institution | 5.827.416 | 7,31% | US$ 61,39M | 2025-11-01 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 5.323.356 | 6,67% | US$ 56,08M | 2025-11-01 |
| Invesco Ltd. | Institution | 4.317.426 | 5,41% | US$ 45,48M | 2026-03-31 |
| BlackRock, Inc. | Institution | 4.061.996 | 5,09% | US$ 42,79M | 2026-03-31 |
| Millennium Management LLC | Institution | 4.022.909 | 5,04% | US$ 42,38M | 2026-03-31 |
| Abingworth LLP | Institution | 3.496.808 | 4,38% | US$ 36,84M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 2.583.636 | 3,24% | US$ 27,22M | 2026-03-31 |
| Abingworth Bioventures 8 LP | Institution | 2.061.702 | 2,59% | US$ 21,72M | 2025-08-28 |
| New Enterprise Associates, Inc. | Institution | 1.960.169 | 2,46% | US$ 20,65M | 2026-03-31 |
| 683 Capital Management, LLC | Institution | 1.850.000 | 2,32% | US$ 19,49M | 2026-03-31 |
| Ensign Peak Advisors, Inc. | Institution | 1.627.806 | 2,04% | US$ 17,15M | 2026-03-31 |
| Catalys Pacific | Institution | 1.493.854 | 1,87% | US$ 15,74M | 2026-03-31 |
| Abingworth Bioventures VII LP | Institution | 1.435.106 | 1,80% | US$ 15,12M | 2025-08-28 |
| GW&K Investment Management, LLC | Institution | 1.421.109 | 1,78% | US$ 14,97M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1.386.890 | 1,74% | US$ 14,61M | 2026-03-31 |
| Wasatch Advisors LP | Institution | 1.340.916 | 1,68% | US$ 14,13M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1.328.045 | 1,67% | US$ 13,99M | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 1.255.161 | 1,57% | US$ 13,22M | 2025-12-31 |
| Mr. David Socks | Insider | 1.220.756 | 1,53% | US$ 12,86M | 2025-04-07 |
| Nomura Investment Management Business Trust | Institution | 1.205.369 | 1,51% | US$ 12,70M | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 1.088.365 | 1,36% | US$ 11,47M | 2025-08-18 |
| Crestline Investors Inc. | Institution | 995.885 | 1,25% | US$ 10,49M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 994.482 | 1,25% | US$ 10,48M | 2026-03-31 |
| Frazier Life Sciences XI, L.P. | Institution | 980.286 | 1,23% | US$ 10,33M | 2025-11-01 |
| Perceptive Advisors LLC | Institution | 925.000 | 1,16% | US$ 9,74M | 2026-03-31 |
| Marshall Wace LLP | Institution | 860.692 | 1,08% | US$ 9,07M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 666.029 | 0,84% | US$ 7,02M | 2026-03-31 |
| EcoR1 Capital, LLC | Institution | 625.000 | 0,78% | US$ 6,58M | 2026-03-31 |
| Propel Bio Management, LLC | Institution | 578.886 | 0,73% | US$ 6,10M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 540.370 | 0,68% | US$ 5,69M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 482.136 | 0,60% | US$ 5,08M | 2026-03-31 |
| StepStone Group Inc. | Institution | 422.085 | 0,53% | US$ 4,45M | 2026-03-31 |
| UBS Asset Management AG | Institution | 416.159 | 0,52% | US$ 4,38M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 414.956 | 0,52% | US$ 4,37M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 409.015 | 0,51% | US$ 4,31M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
